Atrial natriuretic fator: Physiologic actions and implications in congestive heart failure

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Atrial natriuretic factor (ANF) represents a newly recognized hormone of cardiac origin. This peptide is synthesized by the myocardial cells of both atria and released by atrial stretch. The hormone promotes sodium and water excretion by the kidney, inhibits the renin-angiotensin-aldosterone system, and reduces systemic arterial pressure. Specific receptors for ANF are present in the kidney, adrenal glands, vascular smooth muscle, platelets and central nervous system. Congestive heart failure is characterized by increased circulating levels of ANF; however, there appears to be an attenuation in the renal response to the hormone. Recent investigations have reported the effect of systemic administration of synthetic ANF to normal individuals and those with congestive heart failure. The hormone may promote a significant natriuresis and diuresis in addition to reducing arterial pressure and inhibiting renin and aldosterone secretion. Substantial questions remain as to the full physiologic significance and therapeutic potential of this hormone.

Original languageEnglish (US)
Pages (from-to)89-100
Number of pages12
JournalCardiovascular Drugs and Therapy
Volume1
Issue number1
StatePublished - 1987

Fingerprint

Heart Failure
Hormones
Atrial Natriuretic Factor
Kidney
Arterial Pressure
Atrial Natriuretic Factor Receptors
Natriuresis
Diuresis
Renin-Angiotensin System
Adrenal Glands
Aldosterone
Vascular Smooth Muscle
Renin
Blood Platelets
Central Nervous System
Sodium
Peptides
Water
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pharmacology (medical)
  • Pharmacology

Cite this

Atrial natriuretic fator : Physiologic actions and implications in congestive heart failure. / Edwards, Brooks Sayre; Zimmerman, R. S.; Burnett, John C Jr.

In: Cardiovascular Drugs and Therapy, Vol. 1, No. 1, 1987, p. 89-100.

Research output: Contribution to journalArticle

@article{c0c210f2be6a4db58f34a6db9a13f1e3,
title = "Atrial natriuretic fator: Physiologic actions and implications in congestive heart failure",
abstract = "Atrial natriuretic factor (ANF) represents a newly recognized hormone of cardiac origin. This peptide is synthesized by the myocardial cells of both atria and released by atrial stretch. The hormone promotes sodium and water excretion by the kidney, inhibits the renin-angiotensin-aldosterone system, and reduces systemic arterial pressure. Specific receptors for ANF are present in the kidney, adrenal glands, vascular smooth muscle, platelets and central nervous system. Congestive heart failure is characterized by increased circulating levels of ANF; however, there appears to be an attenuation in the renal response to the hormone. Recent investigations have reported the effect of systemic administration of synthetic ANF to normal individuals and those with congestive heart failure. The hormone may promote a significant natriuresis and diuresis in addition to reducing arterial pressure and inhibiting renin and aldosterone secretion. Substantial questions remain as to the full physiologic significance and therapeutic potential of this hormone.",
author = "Edwards, {Brooks Sayre} and Zimmerman, {R. S.} and Burnett, {John C Jr.}",
year = "1987",
language = "English (US)",
volume = "1",
pages = "89--100",
journal = "Cardiovascular Drugs and Therapy",
issn = "0920-3206",
publisher = "Kluwer Academic Publishers",
number = "1",

}

TY - JOUR

T1 - Atrial natriuretic fator

T2 - Physiologic actions and implications in congestive heart failure

AU - Edwards, Brooks Sayre

AU - Zimmerman, R. S.

AU - Burnett, John C Jr.

PY - 1987

Y1 - 1987

N2 - Atrial natriuretic factor (ANF) represents a newly recognized hormone of cardiac origin. This peptide is synthesized by the myocardial cells of both atria and released by atrial stretch. The hormone promotes sodium and water excretion by the kidney, inhibits the renin-angiotensin-aldosterone system, and reduces systemic arterial pressure. Specific receptors for ANF are present in the kidney, adrenal glands, vascular smooth muscle, platelets and central nervous system. Congestive heart failure is characterized by increased circulating levels of ANF; however, there appears to be an attenuation in the renal response to the hormone. Recent investigations have reported the effect of systemic administration of synthetic ANF to normal individuals and those with congestive heart failure. The hormone may promote a significant natriuresis and diuresis in addition to reducing arterial pressure and inhibiting renin and aldosterone secretion. Substantial questions remain as to the full physiologic significance and therapeutic potential of this hormone.

AB - Atrial natriuretic factor (ANF) represents a newly recognized hormone of cardiac origin. This peptide is synthesized by the myocardial cells of both atria and released by atrial stretch. The hormone promotes sodium and water excretion by the kidney, inhibits the renin-angiotensin-aldosterone system, and reduces systemic arterial pressure. Specific receptors for ANF are present in the kidney, adrenal glands, vascular smooth muscle, platelets and central nervous system. Congestive heart failure is characterized by increased circulating levels of ANF; however, there appears to be an attenuation in the renal response to the hormone. Recent investigations have reported the effect of systemic administration of synthetic ANF to normal individuals and those with congestive heart failure. The hormone may promote a significant natriuresis and diuresis in addition to reducing arterial pressure and inhibiting renin and aldosterone secretion. Substantial questions remain as to the full physiologic significance and therapeutic potential of this hormone.

UR - http://www.scopus.com/inward/record.url?scp=0023165056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023165056&partnerID=8YFLogxK

M3 - Article

C2 - 2978996

AN - SCOPUS:0023165056

VL - 1

SP - 89

EP - 100

JO - Cardiovascular Drugs and Therapy

JF - Cardiovascular Drugs and Therapy

SN - 0920-3206

IS - 1

ER -